Open AccessBook
Principles of modern heterocyclic chemistry
Reads0
Chats0
TLDR
The principles of modern heterocyclic chemistry are discussed in this article, with a focus on the use of modern HOGs in modern heterochyclic chemies.Abstract:
Principles of modern heterocyclic chemistry , Principles of modern heterocyclic chemistry , کتابخانه مرکزی دانشگاه علوم پزشکی تهرانread more
Citations
More filters
Patent
Cysteine engineered antibodies and conjugates
TL;DR: In this paper, the authors presented a method for the design, preparation, screening, and selection of the cysteine engineered antibodies (ThioFab) by replacing one or more amino acids of a parent antibody with non-cross-linked, highly reactive cysteines amino acids.
Patent
Monomethylvaline compounds capable of conjugation to ligands
Svetlana O. Doronina,Peter D. Senter,Brian E. Toki,Allen J. Ebens,Toni Beth Kline,Paul Polakis,Mark X. Sliwkowski,Susan D. Spencer +7 more
TL;DR: Auristatin peptides, including MeVal-Val-Dil-Dap-Norephedrine (MMAE) and MeValVal-Vil Dap-Phe(MMAF), were prepared and attached to Ligands through various linkers, including maleimidocaproyl-val-cit-PAB as discussed by the authors.
Patent
Antibody-drug conjugates and methods
Allen J. Ebens,Frederic S. Jacobson,Paul Polakis,Ralph H. Schwall,Mark X. Sliwkowski,Susan D. Spencer +5 more
TL;DR: In this paper, the present invention relates to antibody-drug conjugate compounds of Formula I: Ab-(L-D)p where one or more maytansinoid drug moieties (D) are covalently linked by L to an antibody (Ab) which binds to an ErbB receptor, or which binding to one of the tumor-associated antigens or cell-surface receptors.
Patent
Modulators of toll-like receptors
Manoj C. Desai,Randall L. Halcomb,Paul Hrvatin,Hui Hon Chung,Ryan Mcfadden,Paul A. Roethle,Yang Hong +6 more
TL;DR: In this paper, the present application includes novel modulators of TLRs, compositions containing such compounds, therapeutic methods that include the administration of such compounds and therapeutic methods for TLRs.
Patent
2,4-pyrimidinediamine compounds and their uses
Rajinder Singh,Ankush Argade,Donald G. Payan,Susan M. Molineaux,Sasha J Holland,Jeffrey Clough,Holger Keim,Somasekhar Bhamidipati,Catherine Sylvain,Hui Li,Alexander B. Rossi +10 more
TL;DR: In this article, a 2,4-pyrimidinediamine compound was proposed to inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and using the compounds in a variety of contexts.